Thermo Fisher Scientific Gross Profit 2006-2019 | TMO
- Thermo Fisher Scientific gross profit for the quarter ending September 30, 2019 was $2.763B, a 5.66% increase year-over-year.
- Thermo Fisher Scientific gross profit for the twelve months ending September 30, 2019 was $11.217B, a 5.78% increase year-over-year.
- Thermo Fisher Scientific annual gross profit for 2018 was $10.857B, a 14.91% increase from 2017.
- Thermo Fisher Scientific annual gross profit for 2017 was $9.448B, a 12.85% increase from 2016.
- Thermo Fisher Scientific annual gross profit for 2016 was $8.372B, a 7.94% increase from 2015.
Thermo Fisher Scientific Annual Gross Profit (Millions of US $) |
|
---|---|
2018 | $10,857 |
2017 | $9,448 |
2016 | $8,372 |
2015 | $7,756 |
2014 | $7,492 |
2013 | $5,529 |
2012 | $5,296 |
2011 | $4,794 |
2010 | $4,262 |
2009 | $3,898 |
2008 | $4,206 |
2007 | $3,804 |
2006 | $1,568 |
2005 | $1,195 |
Thermo Fisher Scientific Quarterly Gross Profit (Millions of US $) |
|
---|---|
Q3 2019 | $2,763 |
Q2 2019 | $2,823 |
Q1 2019 | $2,707 |
Q4 2018 | $2,924 |
Q3 2018 | $2,615 |
Q2 2018 | $2,738 |
Q1 2018 | $2,580 |
Q4 2017 | $2,671 |
Q3 2017 | $2,300 |
Q2 2017 | $2,284 |
Q1 2017 | $2,193 |
Q4 2016 | $2,282 |
Q3 2016 | $2,054 |
Q2 2016 | $2,079 |
Q1 2016 | $1,958 |
Q4 2015 | $2,108 |
Q3 2015 | $1,883 |
Q2 2015 | $1,942 |
Q1 2015 | $1,823 |
Q4 2014 | $2,092 |
Q3 2014 | $1,934 |
Q2 2014 | $1,847 |
Q1 2014 | $1,620 |
Q4 2013 | $1,482 |
Q3 2013 | $1,348 |
Q2 2013 | $1,363 |
Q1 2013 | $1,336 |
Q4 2012 | $1,386 |
Q3 2012 | $1,298 |
Q2 2012 | $1,321 |
Q1 2012 | $1,290 |
Q4 2011 | $1,294 |
Q3 2011 | $1,219 |
Q2 2011 | $1,161 |
Q1 2011 | $1,120 |
Q4 2010 | $1,085 |
Q3 2010 | $1,062 |
Q2 2010 | $1,049 |
Q1 2010 | $1,066 |
Q4 2009 | $1,011 |
Q3 2009 | $1,011 |
Q2 2009 | $988 |
Q1 2009 | $887 |
Q4 2008 | $1,067 |
Q3 2008 | $1,033 |
Q2 2008 | $1,088 |
Q1 2008 | $1,018 |
Q4 2007 | $1,040 |
Q3 2007 | $948 |
Q2 2007 | $937 |
Q1 2007 | $880 |
Q4 2006 | $594 |
Q3 2006 | $337 |
Q2 2006 | $325 |
Q1 2006 | $313 |
Q4 2005 | $343 |
Q3 2005 | $306 |
Q2 2005 | $287 |
Q1 2005 | $259 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $127.547B | $24.358B |
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics. The Company's four premier brands include Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services. Its portfolio of products includes technologies for mass spectrometry, elemental analysis, molecular spectroscopy, sample preparation, informatics, purity chemistry production, protein analysis, Ribonucleic acid (RNA)-interference techniques, immunodiagnos. Thermo Fisher Scientific Inc. is headquartered in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Intuitive Surgical (ISRG) | United States | $66.430B | 52.21 |
Edwards Lifesciences (EW) | United States | $48.038B | 43.62 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $21.889B | 14.81 |
IDEXX Laboratories (IDXX) | United States | $21.484B | 51.96 |
Olympus (OCPNY) | Japan | $20.008B | 150.26 |
DexCom (DXCM) | United States | $19.437B | 174.07 |
Teleflex (TFX) | United States | $16.425B | 33.34 |
Sysmex ADR (SSMXY) | Japan | $14.351B | 38.63 |
SONOVA HOLDING (SONVY) | Switzerland | $14.289B | 0.00 |
Hologic (HOLX) | United States | $14.104B | 21.56 |
STERIS (STE) | Ireland | $13.029B | 28.78 |
Varian Medical Systems (VAR) | United States | $12.655B | 30.00 |
Masimo (MASI) | United States | $8.225B | 49.11 |
ABIOMED (ABMD) | United States | $8.077B | 43.95 |
Globus Medical (GMED) | United States | $5.655B | 34.90 |
SARTORIUS AG (SARTF) | Germany | $5.614B | 49.28 |
Penumbra (PEN) | United States | $5.470B | 178.03 |
Integra LifeSciences Holdings (IART) | United States | $5.260B | 22.60 |
Elekta AB (EKTAY) | Sweden | $4.707B | 36.24 |
LivaNova (LIVN) | United Kingdom | $3.814B | 27.46 |
Wright Medical Group (WMGI) | Netherlands | $3.744B | 226.92 |
Tandem Diabetes Care (TNDM) | United States | $3.562B | 0.00 |
Nevro (NVRO) | United States | $3.353B | 0.00 |
Cantel Medical (CMD) | United States | $3.129B | 30.63 |
Integer Holdings (ITGR) | United States | $2.568B | 17.58 |
Nihon Kohden (NHNKY) | Japan | $2.401B | 24.16 |
Glaukos (GKOS) | United States | $2.087B | 0.00 |
Inogen (INGN) | United States | $1.575B | 49.73 |
AVANOS MEDICAL, INC (AVNS) | United States | $1.572B | 30.93 |
Veracyte (VCYT) | United States | $1.401B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $1.242B | 141.85 |
Silk Road Medical (SILK) | United States | $1.076B | 0.00 |
Natus Medical (NTUS) | United States | $1.063B | 25.55 |
Mesa Laboratories (MLAB) | United States | $1.046B | 38.76 |
OPKO Health (OPK) | United States | $1.005B | 0.00 |
CryoLife (CRY) | United States | $0.972B | 99.65 |
Luminex (LMNX) | United States | $0.941B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.868B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.857B | 28.47 |
Pacific Biosciences Of California (PACB) | United States | $0.817B | 0.00 |
AxoGen (AXGN) | United States | $0.660B | 0.00 |
Intersect ENT (XENT) | United States | $0.659B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.595B | 0.00 |
AngioDynamics (ANGO) | United States | $0.583B | 20.95 |
Quotient (QTNT) | Switzerland | $0.577B | 0.00 |
Si-Bone (SIBN) | United States | $0.460B | 0.00 |
Oxford Immunotec Global (OXFD) | United Kingdom | $0.457B | 13.82 |
ViewRay (VRAY) | United States | $0.423B | 0.00 |
Sientra (SIEN) | United States | $0.418B | 0.00 |
Alphatec Holdings (ATEC) | United States | $0.399B | 0.00 |
GenMark Diagnostics (GNMK) | United States | $0.314B | 0.00 |
Stereotaxis (STXS) | United States | $0.299B | 0.00 |
Semler Scientific (SMLR) | United States | $0.293B | 40.82 |
IRadimed (IRMD) | United States | $0.275B | 38.56 |
Accuray (ARAY) | United States | $0.251B | 0.00 |
CRH Medical (CRHM) | Canada | $0.244B | 68.00 |
SeaSpine Holdings (SPNE) | United States | $0.229B | 0.00 |
Fluidigm (FLDM) | United States | $0.204B | 0.00 |
RTI Surgical (RTIX) | United States | $0.163B | 44.20 |
EDAP TMS S.A (EDAP) | France | $0.133B | 35.38 |
Spectral Diagnostics (EDTXF) | Canada | $0.133B | 0.00 |
Restoration Robotics (VERO) | Canada | $0.133B | 0.00 |
ConforMIS (CFMS) | United States | $0.107B | 0.00 |
Second Sight Medical Products (EYES) | United States | $0.098B | 0.00 |
Neuronetics (STIM) | United States | $0.084B | 0.00 |
Vermillion (VRML) | United States | $0.073B | 0.00 |
Electromed (ELMD) | United States | $0.072B | 25.67 |
Apollo Endosurgery (APEN) | United States | $0.063B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.061B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.056B | 0.00 |
Bioanalytical Systems (BASI) | United States | $0.046B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.043B | 0.00 |
TransEnterix (TRXC) | United States | $0.042B | 0.00 |
HTG Molecular Diagnostics (HTGM) | United States | $0.038B | 0.00 |
Neovasc (NVCN) | Canada | $0.025B | 0.00 |
Xtant Medical Holdings (XTNT) | United States | $0.022B | 0.00 |
Navidea Biopharmaceuticals (NAVB) | United States | $0.019B | 0.00 |
ReWalk Robotics (RWLK) | Israel | $0.019B | 0.00 |
DarioHealth (DRIO) | Israel | $0.016B | 0.00 |
American Shared Hospital Services (AMS) | United States | $0.015B | 20.83 |
OBALON THERPTCS (OBLN) | United States | $0.014B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.014B | 0.00 |
Avinger (AVGR) | United States | $0.014B | 0.00 |
Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
Ra Medical Systems (RMED) | United States | $0.012B | 0.00 |
Lianluo Smart (LLIT) | China | $0.008B | 0.00 |
Micron Solutions (MICR) | United States | $0.007B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.007B | 0.00 |
Dynatronics (DYNT) | United States | $0.006B | 0.00 |
Allied Healthcare Products (AHPI) | United States | $0.004B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
Sunshine Heart Inc (CHFS) | United States | $0.003B | 0.00 |
InspireMD (NSPR) | Israel | $0.003B | 0.00 |
Viveve Medical (VIVE) | United States | $0.001B | 0.00 |